Pharmaceutical marketing of over-the-counter drugs in the current digital era: A review

Q4 Pharmacology, Toxicology and Pharmaceutics

Pharmaceutical Sciences Asia Pub Date : 2022-01-01 DOI:10.29090/psa.2022.02.21.102

Mohamad Saleem Anis, Mohamed Azmi Hassali

{"title":"Pharmaceutical marketing of over-the-counter drugs in the current digital era: A review","authors":"Mohamad Saleem Anis, Mohamed Azmi Hassali","doi":"10.29090/psa.2022.02.21.102","DOIUrl":null,"url":null,"abstract":"Digitization is a current era trend that has permeated various daily activities of individuals and businesses. The acceleration of digital adoption can be seen even more with the onset of the COVID-19 pandemic. As a result, a new pattern of pharmaceutical marketing has been defined in the industry in several terms, most notably pharmaceutical digital marketing (PDM). Undeniably, over-the-counter (OTC) drugs, which are pharma-ceuticals sold without a medical prescription, are the most affected drug category by this digital transformation in the pharma industry. The content of this review paper is based on secondary data derived from recent literature and Internet sources. The relevant information from various journal articles, books, reports, and reliable web pages has been presented and discussed. Basically, the main body of the review was divided into two fundamental areas of PDM, with a greater emphasis on the context of OTC drugs: (1) online pharmacies (e-commerce marketing);(2) promotional advertising. In a nutshell, this review provides valuable insights into the emerging concepts of PDM within the scope of OTC drugs.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"60 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Sciences Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29090/psa.2022.02.21.102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}

引用次数: 0

Abstract

Digitization is a current era trend that has permeated various daily activities of individuals and businesses. The acceleration of digital adoption can be seen even more with the onset of the COVID-19 pandemic. As a result, a new pattern of pharmaceutical marketing has been defined in the industry in several terms, most notably pharmaceutical digital marketing (PDM). Undeniably, over-the-counter (OTC) drugs, which are pharma-ceuticals sold without a medical prescription, are the most affected drug category by this digital transformation in the pharma industry. The content of this review paper is based on secondary data derived from recent literature and Internet sources. The relevant information from various journal articles, books, reports, and reliable web pages has been presented and discussed. Basically, the main body of the review was divided into two fundamental areas of PDM, with a greater emphasis on the context of OTC drugs: (1) online pharmacies (e-commerce marketing);(2) promotional advertising. In a nutshell, this review provides valuable insights into the emerging concepts of PDM within the scope of OTC drugs.

查看原文本刊更多论文

数字时代非处方药的医药营销综述

数字化是当前的时代趋势，已经渗透到个人和企业的各种日常活动中。随着2019冠状病毒病(COVID-19)大流行的爆发，数字化应用的加速更加明显。因此，一种新的医药营销模式在业内被定义为几个术语，最引人注目的是医药数字营销(PDM)。不可否认，非处方药(OTC)是受制药行业数字化转型影响最大的药品类别。OTC是指在没有医疗处方的情况下销售的药品。这篇综述文章的内容是基于从最近的文献和互联网来源获得的二手数据。来自各种期刊文章、书籍、报告和可靠网页的相关信息已被呈现和讨论。基本上，审查的主体分为PDM的两个基本领域，更强调非处方药的背景:(1)在线药店(电子商务营销);(2)促销广告。简而言之，这篇综述为非处方药范围内PDM的新兴概念提供了有价值的见解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmaceutical Sciences Asia Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)

CiteScore

0.90

自引率

0.00%

发文量

期刊介绍： The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: Clinical Pharmacy Drug Synthesis and Discovery Targeted-Drug Delivery Pharmaceutics Biopharmaceutical Sciences Phytopharmaceutical Sciences Pharmacology and Toxicology Pharmaceutical Chemistry Nutraceuticals and Functional Foods Natural Products Social, Economic, and Administrative Pharmacy Clinical Drug Evaluation and Drug Policy Making Antimicrobials, Resistance and Infection Control Pharmacokinetics and Pharmacodynamics.